检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张飞飞 张梦[2] 王中山 ZHANG Feifei;ZHANG Meng;WANG Zhongshan(Jiangsu Provincical Key Laboratory of Anesthesiology,College of Anesthesiology,Xuzhou Medical University,Xuzhou 221004,China;不详)
机构地区:[1]徐州医科大学麻醉学院,江苏省麻醉学重点实验室,江苏徐州221004 [2]徐州市中心医院,东南大学附属医院妇产科,江苏徐州221009
出 处:《实用医学杂志》2021年第22期2840-2844,共5页The Journal of Practical Medicine
基 金:国家自然科学基金(编号:81600969)。
摘 要:目的获得ETAR羧基末端58个氨基酸的多肽(ETAR-C58),探讨其对黑色素瘤A375细胞迁移和侵袭的影响。方法通过PCR方法获得ETAR-C58碱基序列,将其克隆到原核表达载体pWaldoGFPe,转化到大肠杆菌BL21(DE3),诱导表达后,经镍柱亲和层析和分子筛层析,得到重组融合多肽,SDSPAGE分析多肽表达量和纯度,免疫印迹做进一步的鉴定。最后采用Transwell法测定A375细胞的迁移和侵袭能力。结果成功构建了重组表达载体pWaldo-ETAR-C58,优化表达条件获得了约90%的可溶性蛋白表达量,纯化获得纯度高达95%的融合多肽,免疫印迹的曝光条带和重组多肽的大小相一致,加入2μmol/L ETAR-C58后,A375细胞的迁移和侵袭能力显著下降(P <0.05)。结论 ETAR-C58多肽具有抗黑色素瘤的活性,为下一步的临床应用奠定了良好的基础。Objective To obtain the 58 amino acid peptide of the carboxyl terminal of ETAR(ETARC58)and investigate the effects on the migration and invasion of melanoma A375 cells. Methods ETAR-C58 sequence was amplified by PCR,inserted into the vector pWaldo-GFPe and then transformed into Escherichia coli BL21(DE3). After expression,the fusion peptide was purified by nickel column affinity chromatography and gel filtration chromatography,analyzed by SDS-PAGE and further identified by immunoblotting. Finally,Transwell assay was carried out to measure the migration and invasion of A375 cells. Results The recombinant expression vector pWaldo-ETAR-C58 was successfully constructed and the soluble fusion peptide was accounted for approximately 90%. SDS-PAGE and immunoblotting results verified the successful purification of the ETAR-C58 with nearly95% purity. ETAR-C58 peptide could inhibit A375 cell migration and invasion at 2 μmol/L. Conclusion The ETAR-C58 peptide have anti-melanoma activity,which allows a possibility for further clinical application.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.143.115.168